100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results...

100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results..., Headache: The Journal of Head and Face Pain, EarlyView. , Headache: The Journal of Head and Face Pain, EarlyView.
, admin,

No comments: